Thermo Fisher Scientific (TMO): FMR LLC now owns 6% of TMO as a passive investor 6.0%

6.0%

Stake

22.3M

Shares owned

Stake as of

Sep 30, 2026

Filed

Nov 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 12, 2024CongressDisclosed sale of TMO — reported range $1,001 - $15,000
2. Aug 5, 2026Insider · 1 personInsiders: 22 sales (~$8.6M)
3. Aug 6, 2026Insider · 2 peopleInsiders: 19 sales (~$12.0M)
4. Aug 7, 2026Insider · 2 peopleInsiders: 28 sales (~$3.1M)
5. Aug 11, 2026Insider · 1 personInsiders: 2 sales (~$15.3M)
6. Aug 14, 2026FDARecall: Ion Torrent Genexus Dx with software, Catalog: A40003539, which supports the Ion Torrent Genexus Dx Integrated Sequencer
7. Aug 19, 2026Insider · Their largest sale since 2024Officer sold ~$7.01M of TMO shares in the open market
8. Aug 20, 2026Insider · 1 personInsiders: 7 sales (~$5.9M)

What came next

1. Oct 15, 2026FDAFDA device clearance: Oncomine ™ Dx Express Test
2. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
3. Oct 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 27, 2026, Thermo Fisher Scientific Inc. (the “Company”), announced that Michael D. Shafer, Executive Vice President of the Company, will retire effective December 31, 2026. 2”
4. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.0%

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 24 insider filings (SEC Form 4 or Form 144), 3 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Thermo Fisher Scientific

• SEC Form 144Nov 13, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 144Oct 28, 2026
• USAspending.gov award recordSep 30, 2026
• USAspending.gov award recordSep 30, 2026
• USAspending.gov award recordSep 29, 2026

Everything OQRO holds on this company is on its TMO page.